skip to main content

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->4)]-n-acetyl-beta-d-glucosaminyl-(1->3)-[beta-d-galactosyl-(1->4)-(alpha-l-fucosyl-(1->3))-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(t18:0)(1-)
... > organooxygen compound > sphingolipid > ceramide > oligoglycosylceramide > fucosyl oligoglycosylceramide > alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-[beta-d-galactosyl-(1->4)-(alpha-l-fucosyl-(1->3))-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->4)]-n-acetyl-beta-d-glucosaminyl-(1->3)-[beta-d-galactosyl-(1->4)-(alpha-l-fucosyl-(1->3))-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(t18:0)(1-)
... > organooxygen compound > carboxamide > ceramide > oligoglycosylceramide > fucosyl oligoglycosylceramide > alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-[beta-d-galactosyl-(1->4)-(alpha-l-fucosyl-(1->3))-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->4)]-n-acetyl-beta-d-glucosaminyl-(1->3)-[beta-d-galactosyl-(1->4)-(alpha-l-fucosyl-(1->3))-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(t18:0)(1-)
... > organooxygen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > fucosyl oligoglycosylceramide > alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-[beta-d-galactosyl-(1->4)-(alpha-l-fucosyl-(1->3))-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->4)]-n-acetyl-beta-d-glucosaminyl-(1->3)-[beta-d-galactosyl-(1->4)-(alpha-l-fucosyl-(1->3))-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(t18:0)(1-)
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > lacto-series glycosphingolipid > alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-[beta-d-galactosyl-(1->4)-(alpha-l-fucosyl-(1->3))-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->4)]-n-acetyl-beta-d-glucosaminyl-(1->3)-[beta-d-galactosyl-(1->4)-(alpha-l-fucosyl-(1->3))-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(t18:0)(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > lacto-series glycosphingolipid > alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-[beta-d-galactosyl-(1->4)-(alpha-l-fucosyl-(1->3))-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->4)]-n-acetyl-beta-d-glucosaminyl-(1->3)-[beta-d-galactosyl-(1->4)-(alpha-l-fucosyl-(1->3))-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(t18:0)(1-)
... > organooxygen compound > sphingolipid > glycosphingolipid > lacto-series glycosphingolipid > alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-[beta-d-galactosyl-(1->4)-(alpha-l-fucosyl-(1->3))-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->4)]-n-acetyl-beta-d-glucosaminyl-(1->3)-[beta-d-galactosyl-(1->4)-(alpha-l-fucosyl-(1->3))-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(t18:0)(1-)

اصطلاح مرجح

alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->4)]-n-acetyl-beta-d-glucosaminyl-(1->3)-[beta-d-galactosyl-(1->4)-(alpha-l-fucosyl-(1->3))-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(t18:0)(1-)  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

بار

  • -1

فرمول

  • C82H140N4O50R

جرم

  • 1981.989

جرم تک‌ایزوتوپی

  • 1980.85353

اسمایلٓ

  • [C@H]1(O[C@@H]([C@H](O)[C@@H]([C@H]1O)O[C@]2(O[C@]([C@@H]([C@H](C2)O)NC(C)=O)([C@@H]([C@@H](CO)O)O)[H])C([O-])=O)CO)O[C@@H]3[C@H]([C@H](O[C@@H]4[C@H]([C@H](O[C@@H]5[C@H](O[C@@H](OC[C@@H]([C@@H]([C@@H](CCCCCCCCCCCCCC)O)O)NC(=O)*)[C@@H]([C@H]5O)O)CO)O[C@@H]([C@@H]4O)CO[C@H]6[C@@H]([C@H]([C@H](O[C@@H]7O[C@@H]([C@H](O)[C@@H]([C@H]7O)O)CO)[C@H](O6)CO)O[C@@H]8O[C@H]([C@@H](O)[C@H]([C@@H]8O)O)C)NC(C)=O)O)O[C@H](CO)[C@H]3O[C@@H]9O[C@H]([C@@H](O)[C@H]([C@@H]9O)O)C)NC(C)=O

زیرمجموعه

  • 2_STAR

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:142564

این مفهوم را بارگیری کن: